MedCity News
MAY 12, 2024
No matter what form they take, one thing is clear — there is an urgent demand for digital primary care providers to guide patient navigation in the digital health era. The post Healthcare’s Next Void to Fill: Digital Primary Care appeared first on MedCity News.
pharmaphorum
MAY 12, 2024
Moderna’s respiratory syncytial virus (RSV) vaccine has suffered a delay in the US as it chases GSK and Pfizer in the market.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MedCity News
MAY 12, 2024
Hospitals are seeking to offset their expenses any way they can, and some are taking a “two-sided green” approach — meaning pursuing renewable energy initiatives that will save money in the long run. These hospitals are on track to save millions, and some already have. The post ‘Two-Sided Green’: How 4 Health Systems Are Saving Money With Renewable Energy appeared first on MedCity News.
pharmaphorum
MAY 12, 2024
The first person to receive a xenotransplant of a kidney from a pig, Rick Slayman, has died almost two months after the procedure
Advertisement
Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.
MedCity News
MAY 12, 2024
Wave is now in network with Aetna in California, giving 3.5 million members access to the company’s mental health services. The post Mental Health Platform Wave Gains First Payer Contract appeared first on MedCity News.
pharmaphorum
MAY 12, 2024
Pfizer reaches deal with NICE on Vyndaqel for ATTR-CM Phil.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
PharmaTech
MAY 12, 2024
In this project, Thermo Fisher Scientific worked with a multinational biopharmaceutical company to investigate trace element variability in its custom cell culture media. Within a year, using a risk-based, collaborative approach, both teams were able to thoroughly characterize incoming specific raw materials and implement proactive measures for reducing the risk of impurities, ultimately providing the company with a long-term risk mitigation strategy.
Pharmaceutical Commerce
MAY 12, 2024
This document details the benefits of DataX, a revolutionary solution tailored for pharmaceutical manufacturers. Designed to navigate the complexities of managing serialized data for drop shipments, DataX ensures secure, compliant, and efficient data exchange.
PharmaTech
MAY 12, 2024
When evaluating a potential vendor, whether for a catalog medium or custom formulation manufacturing, it is important to ensure it can meet your unique needs. This article details five top considerations to carefully evaluate when selecting a cell culture media supplier. Learn how to maximize confidence in your media supply, optimize productivity and help achieve long-term efficiency.
Pharmaceutical Commerce
MAY 12, 2024
This document outlines key strategies and testing protocols critical for optimizing EPCIS implementation, ensuring that pharmaceutical manufacturers can maintain compliance and operational efficiency.
PharmaTech
MAY 12, 2024
The importance of successfully scaling up cell culture media cannot be overstated. Not starting the process soon enough can introduce issues with solubility, manufacturability, procurement, and cost management. This article considers technical and commercial best practices that drug developers may enact so that they, their suppliers and media manufacturers, and in turn, their cell culture media remain on the most efficient path to market.
Pharmacy Times
MAY 12, 2024
The survey reported that approximately 65% of participants were concerned about their mental health, which is a 15% increase since 2020.
PharmaTech
MAY 12, 2024
Read about the process utilized and results gained from the use of a two-phase scale-up strategy to manufacture three complex dry powder medium (DPM) formulations. The success of these projects relied on consistently producing acceptable prototype and cGMP material within the customer’s specifications and manufacturing timelines.
PharmaTech
MAY 12, 2024
In this podcast, hear from our global experts Martin Gonzalez, PHD and Katharine Sparhawk as they share exclusive details of Pfizer CentreOne’s sterile injectable capabilities from both a technical expertise and business development point of view. Our experts will explore key topics including emerging sterile injectable trends, the company’s approach to flexibility in capacity planning and emerging trends that are shaping the development of complex biologics like ADCs.
Advertisement
Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A
PharmaTech
MAY 12, 2024
Sterile injectables (SI) and complex biologics can be leveraged from both a technical and business development standpoint. Pfizer CentreOne, a CDMO embedded within the Pfizer network, offers services from small scale to large scale for SI and biologic drug substances.
Expert insights. Personalized for you.
123 
Let's personalize your content